Results
|
1761.
|
|
|
1762.
|
|
|
1763.
|
|
|
1764.
|
|
|
1765.
|
|
|
1766.
|
|
|
1767.
|
|
|
1768.
|
|
|
1769.
|
|
|
1770.
|
|
|
1771.
|
|
|
1772.
|
|
|
1773.
|
|
|
1774.
|
|
|
1775.
|
Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma. [electronic resource] by
- Tavera, René J
- Forget, Marie-Andrée
- Kim, Young Uk
- Sakellariou-Thompson, Donastas
- Creasy, Caitlin A
- Bhatta, Ankit
- Fulbright, Orenthial J
- Ramachandran, Renjith
- Thorsen, Shawne T
- Flores, Esteban
- Wahl, Arely
- Gonzalez, Audrey M
- Toth, Christopher
- Wardell, Seth
- Mansaray, Rahmatu
- Radvanyi, Laszlo G
- Gombos, Dan S
- Patel, Sapna P
- Hwu, Patrick
- Amaria, Rodabe N
- Bernatchez, Chantale
- Haymaker, Cara
Producer: 20190912
In:
Journal of immunotherapy (Hagerstown, Md. : 1997) vol. 41
Availability: No items available.
|
|
1776.
|
|
|
1777.
|
Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma. [electronic resource] by
- Klemen, Nicholas D
- Wang, Melinda
- Rubinstein, Jill C
- Olino, Kelly
- Clune, James
- Ariyan, Stephan
- Cha, Charles
- Weiss, Sarah A
- Kluger, Harriet M
- Sznol, Mario
Producer: 20210831
In:
Journal for immunotherapy of cancer vol. 8
Availability: No items available.
|
|
1778.
|
|
|
1779.
|
|
|
1780.
|
|